Longevity Biotech is a Philadelphia-based biotechnology company specializing in the development of breakthrough therapeutics using their innovative Hybridtide peptide scaffold. With a focus on preclinical development, their pipeline includes programs in neuroscience and diabetes, harnessing the unique composition of Hybridtides to fine-tune intracellular signal cascades and demonstrate signal bias.
Utilizing their proprietary databases, Longevity Biotech optimizes absorption parameters and ensures robust durability of their Hybridtides in various biological matrices. Their expertise extends to oral peptide delivery, offering formulation evaluation and optimization services to enhance stability, solubility, and absorption for commercial success. With a commitment to advancing the field of biotechnology, Longevity Biotech is dedicated to developing cutting-edge therapies that have the potential to revolutionize healthcare.
Generated from the website